Healthy volunteers help compare edaravone delivery methods
NCT ID NCT04776135
First seen Jan 11, 2026 · Last updated May 15, 2026 · Updated 22 times
Summary
This study looked at how the drug edaravone enters the bloodstream when given as a liquid by mouth or through a nasogastric tube. Thirty-six healthy Japanese adults took a single dose in a crossover design. The goal was to see if both methods deliver the drug similarly and to check for side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY ADULT SUBJECTS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Investigational site
Tokyo, Toshima-ku, 171-0014, Japan
Conditions
Explore the condition pages connected to this study.